News
U.S. aid cuts could jeopardize the supply of donated drugs that are hailed for their effectiveness in combating neglected ...
Procter & Gamble said Thursday it plans to cut 7,000 jobs, about 15% of its workforce, over two years. The company said it's ...
Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to ...
An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.
The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...
21h
MedPage Today on MSNWin for Added Relacorilant in Platinum-Resistant Ovarian CancerIn addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...
Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...
This was the stock's second consecutive day of gains.
1d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Merck submitted a nonbinding offer for the smaller biotech earlier in the year, according to a media report citing people ...
However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...
Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results